Can Fite Biopharma Ltd ADR Tangible Net Worth Ratio
Can Fite Biopharma Ltd ADR tangible net worth ratio. Can Fite Biopharma Ltd ADR (CANF) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($5.59 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of Can Fite Biopharma Ltd ADR to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Can Fite Biopharma Ltd ADR (2011–2025)
Tangible net worth ratio of Can Fite Biopharma Ltd ADR from 2011 to 2025. This chart shows how Can Fite Biopharma Ltd ADR's Tangible Net Worth Ratio has changed across 14 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of $5.59 Million with intangible assets of $0.00 USD. See CANF net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Can Fite Biopharma Ltd ADR Tangible Net Worth Ratio by Year (2011–2025)
Can Fite Biopharma Ltd ADR tangible net worth ratio by year from 2011 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Can Fite Biopharma Ltd ADR from 2011 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market cap of Can Fite Biopharma Ltd ADR.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $5.59 Million | $0.00 | $9.51 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $5.44 Million | $0.00 | $9.12 Million | ▲ +0.0 pp |
| 2023 | 100.0% | $6.24 Million | $0.00 | $9.99 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $4.47 Million | $0.00 | $9.28 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $14.38 Million | $0.00 | $20.25 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $6.07 Million | $0.00 | $9.52 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $2.44 Million | $0.00 | $8.17 Million | ▲ +0.0 pp |
| 2018 | 100.0% | $3.02 Million | $0.00 | $7.95 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $3.05 Million | $0.00 | $7.83 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $3.87 Million | $0.00 | $10.17 Million | ▲ +0.0 pp |
| 2015 | 100.0% | $10.44 Million | $0.00 | $17.60 Million | ▲ +0.0 pp |
| 2014 | 100.0% | $6.86 Million | $0.00 | $10.19 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $4.46 Million | $0.00 | $6.63 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $3.29 Million | $0.00 | $4.90 Million | — |